Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Next two quarters
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by argentia77on Dec 05, 2015 8:53am
141 Views
Post# 24357310

RE:Next two quarters

RE:Next two quarters

gravedigger51 wrote: Wondering what are the educated predictions on an EPS for the next two quarters as they will be the driving force in share price increases.

something to chew on rather than each other ;)



7 analysts: for Q4 2015: $1.24 to $1.76 consensus: $1.46 (all U.S. dollars)
2 analysts for Q1 2016: $1.60 to $2.05

Financial Times link

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities